Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
Yuan Yu,1–3 Jialu Li,1–3 Xuejun Zhu,4 Xiaowen Tang,2,5 Yangyi Bao,6 Xiang Sun,6 Yuhui Huang,1,2 Fang Tian,4 Xiaomei Liu,1,2 Lin Yang1–3 1The Cyrus Tang Hematology Center, 2Collaborative Innovation Center of Hematology, Soochow University, 3Suzhou Cancer Immunotherapy a...
Main Authors: | Yu Y, Li J, Zhu X, Tang X, Bao Y, Sun X, Huang Y, Tian F, Liu X, Yang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/humanized-cd7-nanobody-based-immunotoxins-exhibit-promising-anti-t-cel-peer-reviewed-article-IJN |
Similar Items
-
Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
by: Gilad Kaplan, et al.
Published: (2016-07-01) -
Cytotoxic Effect of Immunotoxin Containing The Truncated Form of Pseudomonas Exotoxin Cell Lines
by: Elahe Safari, et al.
Published: (2014-06-01) -
Mechanisms of Resistance to Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A in Cancer Therapy
by: Michael Dieffenbach, et al.
Published: (2020-06-01) -
Evaluating the influence of common antibiotics on the efficacy of a recombinant immunotoxin in tissue culture
by: Yuyi Zhu, et al.
Published: (2019-05-01) -
Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
by: Bryan D. Fleming, et al.
Published: (2016-09-01)